Bianca Prikazsky focuses on corporate transactions, including domestic and cross-border mergers and acquisitions for public and private companies across various industries, including financial services, pharmaceutical and consumer products. She has broad experience in a wide range of corporate matters, including strategic investments, corporate reorganizations, corporate governance, and licensing transactions.


  • Pfizer Inc. in its acquisition of Therachon Holding AG, a clinical-stage biotechnology firm focusing on rare diseases.
  • Alcon in its acquisition of PowerVision Inc. a medical device development company focused on creating fluid-based intraocular lens implants.
  • Aduro Biotech in the negotiation of a research collaboration and exclusive license agreement with Eli Lilly & Company for Aduro's cGAS-STING Pathway Inhibitor program for the research and development of novel immunotherapies for autoimmune and other inflammatory diseases.


  • JD, Brooklyn Law School, 2013
  • BA, Communications/Spanish , University of Michigan, 2009
  • New York
  • New Jersey

Email Disclaimer